πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7348314

Compositions and methods for inhibiting viral replication

Alnylam Europe AG Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7344711

Use of adenoviruses mutated in the VA genes for cancer treatment

ONCOLYTICS BIOTECH INC. Β· Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7344722

Cold-adapted influenza virus

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7339037

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, v

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332170

Classical swine fever virus virulence determinant and a novel classical swine fever vaccin

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7332321

Viral fibers

The Board of Regents of the University of Texas System Β· Granted Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7314858

Retrocyclins: antiviral and antimicrobial peptides

The Regents of the University of California Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7314631

Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect agains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7309495

Hemorrhagic feline calicivirus

The Regents of the University of California Β· Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7300650

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. Β· Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7288369

Replication competent hepatitis C virus and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7285383

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. Β· Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7282205

Anti-hepatitis A virus antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7279306

Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferabl

The Regents of the University of Colorado Β· Granted Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7276227

Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7273613

Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders

The Board of Regents of the University of Oklahoma Β· Granted Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7267941

Cyanovirin variant-polymer conjugates

Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Β· Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7264816

Virulent systemic feline calicivirus

The Regents of the University of California Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7264798

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7252989

Adenovirus supervector system

The Board of Regents of the University of Texas System Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7252817

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7250171

Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprote

The United States of America as represented by the Secretary of the Dept. of Health & Human Services Β· Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244435

DNA vaccine expressing HA1 of equine-2 influenza virus

The Board of Regents for Oklahoma State University Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244617

Diminishing viral gene expression by promoter replacement

The Board of Regents of the University of Texas System Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted